Posted On: 07/26/2016 2:45:39 PM
Post# of 72441
CTIX is planning for the acne/atopic dermatitis trial as well. The FDA probably asked for some dermal toxicology studies first. I'm hoping the topical formulation development is going well. Inflammatory skin disease is another huge market.
Quote:
Why would they not start a POC on atopical dermatitis (type of ezcema) knowing that Anacor Pharmaceuticals was bought out by Pfizer for 5.2 billion mainly for their topical ezcema ointment known as Crisaborole.
(1)
(0)
Scroll down for more posts ▼
